InvestorsHub Logo
Followers 425
Posts 20207
Boards Moderated 1
Alias Born 02/22/2010

Re: $heff post# 80462

Wednesday, 07/23/2014 1:51:22 PM

Wednesday, July 23, 2014 1:51:22 PM

Post# of 97237
SNTA-liking chart here and recent News
Synta Pharmaceuticals advances ganetespib into Phase 3 extension of AML LI-1
Synta Pharmaceuticals announced the advancement of ganetespib into the Phase 3 extension of the AML LI-1 trial.
http://www.theflyonthewall.com/permalinks/entry.php/SNTAid2041209/SNTA-Synta-Pharmaceuticals-data-positive--says-JMP-Securities

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.